Retirement Stock Portfolio: Top 15 Stock Picks

Page 12 of 15

4. AbbVie Inc. (NYSE:ABBV)

Dividend Yield: 2.83%

Number of Hedge Fund Holders: 89

AbbVie Inc. (NYSE:ABBV) ranks among the top picks for a retirement portfolio. The FDA received a New Drug Application from AbbVie Inc. (NYSE:ABBV) on September 26 for tavapadon, an experimental oral medication used once daily to treat Parkinson’s disease.

The application is based on data from the Phase 3 TEMPO clinical trial, which assessed tavapadon across the Parkinson’s disease spectrum. The program comprised of two trials in early Parkinson’s disease (TEMPO-1 and TEMPO-2) along with a trial (TEMPO-3) that tested tavapadon as an additional therapy to levodopa in patients with motor irregularities.

At week 26, TEMPO-1 and TEMPO-2 showed a significant increase in the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale Parts II and III combined score compared to baseline.

AbbVie Inc. (NYSE:ABBV) is a biopharmaceutical company that specializes in developing, manufacturing, and marketing therapies for complicated and chronic illnesses. Its next-generation immunology medications, Rinvoq and Skyrizi, continue to drive growth.

Page 12 of 15